Literature DB >> 19187333

Expression profiling of genes related to asthma exacerbations.

T Aoki1, Y Matsumoto, K Hirata, K Ochiai, M Okada, K Ichikawa, M Shibasaki, T Arinami, R Sumazaki, E Noguchi.   

Abstract

BACKGROUND: Asthma is a chronic airway inflammatory disease; however, the molecular mechanisms that underlie asthma exacerbation are only partially understood.
OBJECTIVE: To identify gene expression signatures that reflect the acute exacerbation of asthma, we examined the differential expression of genes during asthma exacerbation and stable condition by using microarray analysis.
METHODS: The subjects were mite-sensitive asthmatic children and non-asthmatic control children. The children were divided into four groups (AE: asthma exacerbation, n=12; SA: stable asthma, n=11; IC: infected control, n=6; and NC: non-infected control, n=5). Total RNA was extracted from peripheral blood mononuclear cells and subjected to microarray analysis with Illumina Human Ref8 BeadChip arrays. Welch's t-test was performed to identify genes whose expression was altered during asthma exacerbation. Quantitative real-time RT-PCR was performed on samples collected from 43 asthmatic children and 11 control children to verify the microarray results.
RESULTS: The expression of 137/16 genes was significantly up/down-regulated during asthma exacerbation assessed by microarray analysis. Of the genes, 62 were also differentially expressed during upper respiratory infection. Many of the asthma exacerbation related genes were involved in defence responses and responses to external stimuli, but these associations disappeared after excluding the infection-related genes. Quantitative real-time RT-PCR confirmed that the genes related (S100A8 and GAS6) and unrelated to infections (CD200 and RBP7) were differentially expressed during asthma exacerbation (P<0.01).
CONCLUSIONS: Previously unidentified immune responses during asthma exacerbation may provide further clarification of the molecular mechanisms underlying asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187333     DOI: 10.1111/j.1365-2222.2008.03186.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  36 in total

1.  Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.

Authors:  Takehiko Shibata; David M Habiel; Ana L Coelho; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  J Immunol       Date:  2014-03-21       Impact factor: 5.422

2.  MicroRNA expression profiling of human blood monocyte subsets highlights functional differences.

Authors:  Truong-Minh Dang; Wing-Cheong Wong; Siew-Min Ong; Peng Li; Josephine Lum; Jinmiao Chen; Michael Poidinger; Francesca Zolezzi; Siew-Cheng Wong
Journal:  Immunology       Date:  2015-07       Impact factor: 7.397

3.  Genomic architecture of asthma differs by sex.

Authors:  Tesfaye B Mersha; Lisa J Martin; Jocelyn M Biagini Myers; Melinda Butsch Kovacic; Hua He; Mark Lindsey; Umasundari Sivaprasad; Weiguo Chen; Gurjit K Khurana Hershey
Journal:  Genomics       Date:  2015-03-25       Impact factor: 5.736

4.  The Innate Immune Protein S100A9 Protects from T-Helper Cell Type 2-mediated Allergic Airway Inflammation.

Authors:  Lauren D Palmer; K Nichole Maloney; Kelli L Boyd; A Kasia Goleniewska; Shinji Toki; C Noel Maxwell; Walter J Chazin; R Stokes Peebles; Dawn C Newcomb; Eric P Skaar
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

5.  Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control.

Authors:  Damien C Croteau-Chonka; Weiliang Qiu; Fernando D Martinez; Robert C Strunk; Robert F Lemanske; Andrew H Liu; Frank D Gilliland; Joshua Millstein; W James Gauderman; Carole Ober; Jerry A Krishnan; Steven R White; Edward T Naureckas; Dan L Nicolae; Kathleen C Barnes; Stephanie J London; Albino Barraza-Villarreal; Vincent J Carey; Scott T Weiss; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2017-01-15       Impact factor: 21.405

6.  Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.

Authors:  Seungwoo Shin; Jong Sook Park; Yoon-Jeong Kim; Taejeong Oh; Sungwhan An; Choon-Sik Park
Journal:  Mol Genet Genomics       Date:  2012-03-29       Impact factor: 3.291

Review 7.  Spectrum of T-lymphocyte activities regulating allergic lung inflammation.

Authors:  Erwin W Gelfand; Anthony Joetham; Meiqin Wang; Katsuyuki Takeda; Michaela Schedel
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

8.  Role of growth arrest-specific gene 6 in the development of fungal allergic airway disease in mice.

Authors:  Takehiko Shibata; Ugur Burcin Ismailoglu; Nicolai A Kittan; Ana Paula Moreira; Ana Lucia Coelho; Geoffrey L Chupp; Steven L Kunkel; Nicholas W Lukacs; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

9.  Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma.

Authors:  Xiting Yan; Jen-Hwa Chu; Jose Gomez; Maria Koenigs; Carole Holm; Xiaoxuan He; Mario F Perez; Hongyu Zhao; Shrikant Mane; Fernando D Martinez; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Stephanie J London; Frank Gilliland; Scott T Weiss; Benjamin A Raby; Lauren Cohn; Geoffrey L Chupp
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

Review 10.  Assessing the human immune system through blood transcriptomics.

Authors:  Damien Chaussabel; Virginia Pascual; Jacques Banchereau
Journal:  BMC Biol       Date:  2010-07-01       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.